Earnings Verdict
Earnings likely ~4/29, 29 days out. IV is normal (41%) with no significant pre-earnings spike yet. The term structure shows a kink in May, suggesting earnings are priced for that cycle. Historical moves are volatile but lack recent revenue data. Best strategy is a short premium play selling the elevated May IV, with risk of a large directional gap.
base 5; -1 no explicit earnings date; -0.5 low liquidity vs mega-caps
Most important: No explicit earnings date; inferred from IV kink at May 1st (31d). Historical EPS surprises are large and mixed.
⚠️Earnings date NOT explicit. Inferred from IV kink at May 1st (31d). Monitor for confirmation.
📊Historical EPS surprise data is extreme but lacks corresponding price move data. Interpret with caution.
⚖️Spot ($11.54) is below near-term max pain ($12), creating a mild upward pull from gamma, but GEX is trending (negative).
Regime Classification
Vol Regime
Normal (IV 41%)
Gamma Regime
Trending (GEX -$38.2M — pro-cyclical)
Flow Regime
Mixed (net prem +$2.9M, P/C 1.09)
Spot vs MP
Below max pain by 3.8% (spot $11.54 vs MP $12)
Gamma flip: ~$8.00 — Gamma flip ~$8 based on heavy put OI. Below $8, dealer hedging could accelerate selling.
Earnings Overview
Next earnings: 2026-04-29 (29 days)inferred
Expected moves:
- 5/01 (31d): ±$1.07 (9.3%) [$10.47 - $12.61]
IV Setup
Term structure: Kink at May 1st (31d): IV 41.1% vs ~34% in April and ~36% in June.
Crush estimate: ~7-10 vol pts, back to ~34%
Skew: Heavy put OI at $7-$8 strikes; flow mixed but net premium positive.
Historical Context
Beat rate: 75% (3/4 quarters)
Avg move vs expected: Cannot calculate precise % move vs expected from provided data. Historical EPS surprises: -33%, +25%, +11%, +557%.
Directional bias: Mixed. Last quarter missed (-33%), prior three beat.
Key Levels
1$8 gamma flip / put OI wall
2$12 max pain (near-term)
3$12.50 / $10.50 (EM bounds approx)
4$14.85 call OI wall
Flow Highlights
Massive $5.00 LEAP call buying ($3.1M net premium).
Strategic long-term bullish positioning, not an earnings trade.
Heavy $13.00 Put (5/08) selling ($1.4M net premium).
Institutional selling of downside protection for May cycle.
Unusual volume in $11.50 Puts (4/10): 8,188 vol vs 2,504 OI.
Near-term bearish flow or hedging ahead of potential earnings.
Strategies
Short Strangle (May Cycle)
Sell $10.50 Put x $13.00 Call 5/01
Trigger: Enter 10-14 days before inferred earnings (mid-April) if IV > 40%.
Sells elevated IV in the May 1st cycle (41.1%). Strikes placed outside the 9.3% EM provide a buffer. Historical volatility of surprises supports a premium-selling approach.
Outperforms: Stock stays within $10.10-$13.40 (wider than EM). IV crushes post-earnings.
Underperforms: Stock gaps beyond breakevens. Losses accelerate beyond $10/$13.50.
Put Credit Spread (Defensive)
Sell $10.00 Put / Buy $9.50 Put 5/01
Trigger: If bullish on earnings and spot holds above $11.50.
Defined risk. Capitalizes on heavy put OI at $10 providing support. Targets the lower half of the expected move range. Max loss is limited.
Outperforms: Stock stays above $10.00. IV crush provides additional benefit.
Underperforms: Stock closes below $9.85 at expiration.
Long Straddle (Low IV Entry)
Buy $11.50 Straddle 5/01
Trigger: Enter only if IV dips below 38% before earnings, suggesting mispricing.
Historical EPS surprises are wildly volatile. If IV is not fully pricing in this potential, a long volatility play could work. High risk of IV crush.
Outperforms: Actual move exceeds 9.3% EM. A surprise on par with historical extremes (>+500% or <-33%).
Underperforms: Stock pins near $11.50 and IV crushes from 41% to ~34%.
Risk Assessment
!Gap Risk: High. Historical EPS surprises are extreme (+557% to -33%). A similar magnitude move on current price would far exceed the 9.3% EM.
!IV Crush: Moderate. IV is only slightly elevated (41% vs 34% baseline). Crush may be 7-10 vol points, hurting long premium strategies.
!Liquidity: Below average vs mega-caps. Wider bid/ask spreads on options, especially OTM. Size positions accordingly.
!Date Uncertainty: Earnings date is inferred, not confirmed. If earnings occur earlier (e.g., April 24th week), strategies using May expiration will have significant residual theta/vega risk.
What to Watch
?IV trajectory in the May 1st expiration as the date approaches.
?Any news confirming the Q1 earnings date (likely last week of April).
?Spot price action relative to the $12 max pain level and the $8 gamma flip zone.